Evidence map›Paper›PMID 40231498›Full record

ArticleCurrent protein & peptide science2025

Firuza Begum, Aman Kumar Mahto, Shalini Kumari, Rikeshwer Prasad Dewangan

Abstract read
PubMed Publisher
In one paragraph

Article in Current protein & peptide science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Firuza BegumDepartment of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research (SPER), Jamia Hamdard (Deemed to be University), New Delhi, 110062, India.
Aman Kumar MahtoDepartment of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research (SPER), Jamia Hamdard (Deemed to be University), New Delhi, 110062, India.
Shalini KumariNucleic acid and Biophysics Laboratory, CSIR-Institute of Genomics and Integrative Biology (IGIB), Mathura Road, Sukhdev Vihar, New Delhi, 110025, India.
Rikeshwer Prasad DewanganDepartment of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research (SPER), Jamia Hamdard (Deemed to be University), New Delhi, 110062, India.ORCID 0000-0001-5537-6919

Funding

Indian Council of Medical Research (ICMR) OMI/14/2020/ECD-I
6 · The paper itself

Abstract

INTRODUCTION/

objectivesSilver nanoparticles (AgNPs) are promising antimicrobial agents, but their synthesis often involves toxic reducing agents. To address this, we developed a green synthesis methodology employing an in-situ approach for synthesizing AgNPs within self- -assembled ultrashort peptide hydrogels through photochemical synthesis, eliminating the need for toxic chemicals.

methodsA novel tetrapeptide was designed and synthesized to form hydrogels in aqueous solutions. AgNPs were incorporated into the hydrogel

resultsAmong the peptides synthesized, PHG-2 formed a hydrogel at a 1% w/v concentration in aqueous solution. Characterization using the gel inversion assay, circular dichroism (CD) spectroscopy, and transmission electron microscopy (TEM) revealed uniform nanofibril self-assembly. UV spectroscopy and TEM confirmed the formation of AgNPs within the hydrogel. While the peptide hydrogel exhibited moderate antibacterial activity alone, the AgNP-loaded hydrogel demonstrated synergistic antibacterial effects against methicillin-resistant

conclusionsThis study introduces a novel ultrashort tetrapeptide sequence for developing antibacterial agents that are effective against infected wounds while supporting wound healing. Utilizing in-situ photochemical synthesis, the green synthesis approach provides an environmentally friendly and sustainable alternative to conventional methods.

Indexed as

Anti-Bacterial AgentsHydrogelsMetal NanoparticlesPeptidesSilverWound HealingEscherichia coliGreen Chemistry TechnologyHumansMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMolecular Docking SimulationAnti-Bacterial AgentsHydrogelsPeptidesSilverantibacterial hydrogelmethicillin-resistant S. aureus.Self-assembled peptidesilver nanoparticlesolid phase peptide synthesiswound healing

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.